Literature DB >> 26857018

Mast Cells and Anaphylaxis.

Phil Lieberman1,2, Lene Heise Garvey3.   

Abstract

For half a century, it has been known that the mast cell is the cell responsible for the majority of anaphylactic events. Its mediators, taken as a whole, are capable of producing all of the clinical manifestations of these events. With the discovery of immunoglobulin E (IgE), it was originally felt that the vast majority of anaphylactic episodes were due to antigen coupling with two cell-bound IgE molecules. More recently it has been learned that many episodes are produced by direct activation of mast cells, not involving antigen binding to IgE, and that monomeric IgE under certain conditions can also cause degranulation. Of note--in regard to antigen independent degranulation--are recent reports that the human G-protein-coupled receptor, MRGPRX2, may be the receptor for many drugs and cationic proteins capable of producing direct mast cell degranulation and anaphylactic events.

Entities:  

Keywords:  Anaphylaxis; Basophil; Immunoglobulin E; MRGPRX2; Mast cell; Mast cell mediators; Mast cell secretagogues; Tryptase

Mesh:

Substances:

Year:  2016        PMID: 26857018     DOI: 10.1007/s11882-016-0598-5

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  37 in total

1.  Histamine in tissue mast cells.

Authors:  J F RILEY; G B WEST
Journal:  J Physiol       Date:  1952-08       Impact factor: 5.182

2.  Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors:  Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

3.  An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment.

Authors:  Eli O Meltzer; Robert B Berkowitz; Elliott B Grossbard
Journal:  J Allergy Clin Immunol       Date:  2005-04       Impact factor: 10.793

4.  Detection of the c-kit D816V mutation in systemic mastocytosis by allele-specific PCR.

Authors:  J A Schumacher; K S J Elenitoba-Johnson; M S Lim
Journal:  J Clin Pathol       Date:  2007-05-25       Impact factor: 3.411

5.  Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis.

Authors:  Cem Akin; Linda M Scott; Can N Kocabas; Nataliya Kushnir-Sukhov; Erica Brittain; Pierre Noel; Dean D Metcalfe
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

6.  Malignant and corticosteroid-dependent idiopathic anaphylaxis: successful responses to ketotifen.

Authors:  R Patterson; E J Fitzsimons; A C Choy; K E Harris
Journal:  Ann Allergy Asthma Immunol       Date:  1997-08       Impact factor: 6.347

7.  Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.

Authors:  Joseph H Butterfield; Catherine R Weiler
Journal:  Int Arch Allergy Immunol       Date:  2008-07-12       Impact factor: 2.749

8.  Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation.

Authors:  P Bradding; I H Feather; S Wilson; P G Bardin; C H Heusser; S T Holgate; P H Howarth
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

9.  Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin.

Authors:  J R Gordon; S J Galli
Journal:  Nature       Date:  1990-07-19       Impact factor: 49.962

Review 10.  Mast cell function: a new vision of an old cell.

Authors:  Elaine Zayas Marcelino da Silva; Maria Célia Jamur; Constance Oliver
Journal:  J Histochem Cytochem       Date:  2014-07-25       Impact factor: 2.479

View more
  18 in total

1.  Drug desensitization in 17-year-old male with Mast Cell Activation Syndrome, pneumonia, and antibiotic hypersensitivities.

Authors:  Patrick Staso; Andrey Leonov
Journal:  AME Case Rep       Date:  2017-11-30

2.  Munc18-2, but not Munc18-1 or Munc18-3, controls compound and single-vesicle-regulated exocytosis in mast cells.

Authors:  Berenice A Gutierrez; Miguel A Chavez; Alejandro I Rodarte; Marco A Ramos; Andrea Dominguez; Youlia Petrova; Alfredo J Davalos; Renan M Costa; Ramon Elizondo; Michael J Tuvim; Burton F Dickey; Alan R Burns; Ruth Heidelberger; Roberto Adachi
Journal:  J Biol Chem       Date:  2018-03-29       Impact factor: 5.157

Review 3.  Beyond IgE-When Do IgE-Crosslinking and Effector Cell Activation Lead to Clinical Anaphylaxis?

Authors:  Lars K Poulsen; Bettina M Jensen; Vanesa Esteban; Lene Heise Garvey
Journal:  Front Immunol       Date:  2017-08-10       Impact factor: 7.561

Review 4.  Epidemiology, Mechanisms, and Diagnosis of Drug-Induced Anaphylaxis.

Authors:  Maria Isabel Montañez; Cristobalina Mayorga; Gador Bogas; Esther Barrionuevo; Ruben Fernandez-Santamaria; Angela Martin-Serrano; Jose Julio Laguna; Maria José Torres; Tahia Diana Fernandez; Inmaculada Doña
Journal:  Front Immunol       Date:  2017-05-29       Impact factor: 7.561

5.  Mast Cells Exert Anti-Inflammatory Effects in an IL10-/- Model of Spontaneous Colitis.

Authors:  E M Lennon; L B Borst; L L Edwards; A J Moeser
Journal:  Mediators Inflamm       Date:  2018-04-17       Impact factor: 4.711

Review 6.  Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers.

Authors:  Teodorikez Wilfox Jimenez-Rodriguez; Marlene Garcia-Neuer; Leila A Alenazy; Mariana Castells
Journal:  J Asthma Allergy       Date:  2018-06-20

7.  Imidazolidinyl urea activates mast cells via MRGPRX2 to induce non-histaminergic allergy.

Authors:  Jiapan Gao; Delu Che; Xueshan Du; Yi Zheng; Huiling Jing; Nan Wang
Journal:  Toxicol Res (Camb)       Date:  2021-04-29       Impact factor: 3.524

Review 8.  Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia.

Authors:  Michael P O'Connell; Jonathan J Lyons
Journal:  Curr Opin Allergy Clin Immunol       Date:  2020-10

9.  Mast cell desensitization inhibits calcium flux and aberrantly remodels actin.

Authors:  W X Gladys Ang; Alison M Church; Mike Kulis; Hae Woong Choi; A Wesley Burks; Soman N Abraham
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

Review 10.  Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis.

Authors:  Lysann Bender; Henri Weidmann; Stefan Rose-John; Thomas Renné; Andy T Long
Journal:  Front Immunol       Date:  2017-09-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.